Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 4Completed 1

Sponsor Class

OTHER 5NIH 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Thoracic 2Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Metabolic Syndrome 1Leukoplakia, Oral 1Inflammation 1Hypogonadism 1Diabetes Mellitus 1

Interventions

Cyclophosphamide 47aldesleukin 30fludarabine phosphate 26fludarabine 24Carboplatin 18Rituximab 16Interleukin-2 16Cisplatin 16Bevacizumab 162,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 16Radiotherapy 15Paclitaxel 15Magnetic Resonance Spectroscopy 14Bortezomib 14Filgrastim 13Doxorubicin 13Oxaliplatin 12Erlotinib Hydrochloride 12Trastuzumab 11Leucovorin 11Etoposide 11Biopsy 11Taxes 10Radiation 10Fluorouracil 10alvocidib 9Specimen Handling 9Sorafenib 9Docetaxel 9Dexamethasone 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × NIH × Pioglitazone × Clear all
NCT01342770 2017-12-05

Pioglitazone Hydrochloride in Treating Patients With Stage IA-IIIA Non-small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Terminated
6 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00951379 2016-04-06

Pioglitazone for Oral Premalignant Lesions

National Cancer Institute (NCI)

Phase 2 Terminated
52 enrolled 23 charts
Head & Neck

Leukoplakia, Oral

NCT00923949 2015-09-30

Pioglitazone to Treat Adults Undergoing Surgery for Non-small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
1 enrolled 7 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00743327 2012-08-06

ADT

National Institutes of Health Clinical Center (CC)

Terminated
1 enrolled

Diabetes Mellitus, Hypogonadism, Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡